Logo of annrheumdAnnals of the Rheumatic DiseasesVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Ann Rheum Dis. 2005 Feb; 64(2): 235–238.
PMCID: PMC1755347

No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis


Objectives: Ankylosing spondylitis (AS) is a multifactorial and polygenic disease. Apart from HLA, other genes very probably play a role in disease susceptibility. Indigenous bacteria of the gastrointestinal flora appear to play a role in the pathogenesis of the disease; therefore, genes controling the innate and acquired immune response are good candidates to study disease susceptibility. CD14 and Toll-like receptor 4 (TLR4) are key receptors for the sensing of bacteria. The CD14 C-260T and TLR4 A896G single nucleotide polymorphims are associated with aberrant signal transduction for bacterial agonists.

Methods: The distribution of the CD14 C-260T and TLR4 A896G polymorphisms was studied in genomic DNA from 113 unrelated white Dutch AS patients and 170 ethnically matched healthy controls. The diagnosis of AS was made according to the modified New York criteria. The CD14 C-260T and TLR4 A896G polymorphisms were genotyped by PCR-RFLP methods.

Results: No significant differences were found between patients and controls in the frequencies of the carriership of the less frequent CD14-260T allele (odds ratio 0.65; 95% confidence interval 0.37 to 1.15) or the TLR4 896G allele (1.68; 0.67 to 4.19).

Conclusions: There is no evidence for involvement of the CD14 C-260T or TLR4 A896G polymorphisms in susceptibility to AS. An important role of bacteria and genetic predisposition of the innate immune system in cases of AS cannot be excluded by these findings. Therefore, studies of the surprisingly highly polymorphic candidate genes in this field should be continued.

Full Text

The Full Text of this article is available as a PDF (178K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. Ankylosing spondylitis and HL-A 27. Lancet. 1973 Apr 28;1(7809):904–907. [PubMed]
  • Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med. 1973 Apr 5;288(14):704–706. [PubMed]
  • Burmester GR, Daser A, Kamradt T, Krause A, Mitchison NA, Sieper J, Wolf N. Immunology of reactive arthritides. Annu Rev Immunol. 1995;13:229–250. [PubMed]
  • van der Paardt M, van Denderen JC, van den Brule AJ, Morré SA, van der Horst-Bruinsma IE, Bezemer PD, Dijkmans BA. Prevalence of Chlamydia trachomatis in urine of male patients with ankylosing spondylitis is not increased. Ann Rheum Dis. 2000 Apr;59(4):300–302. [PMC free article] [PubMed]
  • Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990 Sep 21;249(4975):1431–1433. [PubMed]
  • da Silva Correia J, Soldau K, Christen U, Tobias PS, Ulevitch RJ. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2. J Biol Chem. 2001 Jun 15;276(24):21129–21135. [PubMed]
  • Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem. 1999 Apr 16;274(16):10689–10692. [PubMed]
  • Vabulas RM, Ahmad-Nejad P, da Costa C, Miethke T, Kirschning CJ, Häcker H, Wagner H. Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem. 2001 Aug 17;276(33):31332–31339. [PubMed]
  • LeVan TD, Bloom JW, Bailey TJ, Karp CL, Halonen M, Martinez FD, Vercelli D. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol. 2001 Nov 15;167(10):5838–5844. [PubMed]
  • Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD. A Polymorphism* in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol. 1999 May;20(5):976–983. [PubMed]
  • Hubacek JA, Rothe G, Pit'ha J, Skodová Z, Stanek V, Poledne R, Schmitz G. C(-260)-->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation. 1999 Jun 29;99(25):3218–3220. [PubMed]
  • Obana N, Takahashi S, Kinouchi Y, Negoro K, Takagi S, Hiwatashi N, Shimosegawa T. Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene, CD14. Scand J Gastroenterol. 2002 Jun;37(6):699–704. [PubMed]
  • Klein W, Tromm A, Griga T, Fricke H, Folwaczny C, Hocke M, Eitner K, Marx M, Duerig N, Epplen JT. A polymorphism in the CD14 gene is associated with Crohn disease. Scand J Gastroenterol. 2002 Feb;37(2):189–191. [PubMed]
  • Klein W, Tromm A, Griga T, Folwaczny C, Hocke M, Eitner K, Marx M, Duerig N, Epplen JT. Interaction of polymorphisms in the CARD15 and CD14 genes in patients with Crohn disease. Scand J Gastroenterol. 2003 Aug;38(8):834–836. [PubMed]
  • Repo Heikki, Anttonen Krista, Kilpinen Sami K, Palotie Aarno, Salven Petri, Orpana Arto, Leirisalo-Repo Marjatta. CD14 and TNfa promoter polymorphisms in patients with acute arthritis. Special reference to development of chronic spondyloarthropathy. Scand J Rheumatol. 2002;31(6):355–361. [PubMed]
  • Laval SH, Timms A, Edwards S, Bradbury L, Brophy S, Milicic A, Rubin L, Siminovitch KA, Weeks DE, Calin A, et al. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet. 2001 Apr;68(4):918–926. [PMC free article] [PubMed]
  • Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet. 2000 Jun;25(2):187–191. [PubMed]
  • Erridge Clett, Stewart John, Poxton Ian R. Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling. J Exp Med. 2003 Jun 16;197(12):1787–1791. [PMC free article] [PubMed]
  • von Aulock Sonja, Schröder Nicolas W J, Gueinzius Katja, Traub Stephanie, Hoffmann Sebastian, Graf Kathrin, Dimmeler Stefanie, Hartung Thomas, Schumann Ralf R, Hermann Corinna. Heterozygous toll-like receptor 4 polymorphism does not influence lipopolysaccharide-induced cytokine release in human whole blood. J Infect Dis. 2003 Sep 15;188(6):938–943. [PubMed]
  • van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984 Apr;27(4):361–368. [PubMed]
  • Morré Servaas A, Murillo Laura S, Spaargaren Joke, Fennema Han S A, Peña A Salvador. Role of the toll-like receptor 4 Asp299Gly polymorphism in susceptibility to Candida albicans infection. J Infect Dis. 2002 Nov 1;186(9):1377–1379. [PubMed]
  • Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernández-Sueiro JL, Balish E, Hammer RE. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med. 1994 Dec 1;180(6):2359–2364. [PMC free article] [PubMed]
  • Palm Oyvind, Moum Bjørn, Ongre Aksel, Gran Jan Tore. Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study). J Rheumatol. 2002 Mar;29(3):511–515. [PubMed]
  • Baeten D, De Keyser F, Van Damme N, Veys EM, Mielants H. Influence of the gut and cytokine patterns in spondyloarthropathy. Clin Exp Rheumatol. 2002 Nov-Dec;20(6 Suppl 28):S38–S42. [PubMed]
  • Baeten Dominique, De Keyser Filip, Mielants Herman, Veys Eric M. Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol. 2002 Sep;16(4):537–549. [PubMed]
  • Peña AS. Genetics of inflammatory bowel diseases--past, present, and future. Dig Dis. 2003;21(2):85–90. [PubMed]
  • Hoffman IEA, Demetter P, Peeters M, De Vos M, Mielants H, Veys EM, De Keyser F. Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy. Ann Rheum Dis. 2003 May;62(5):455–459. [PMC free article] [PubMed]
  • Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001 May 31;411(6837):599–603. [PubMed]
  • Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001 May 31;411(6837):603–606. [PubMed]
  • Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJ, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet. 2001 Jun 16;357(9272):1925–1928. [PubMed]
  • Murillo Laura, Crusius J Bart A, van Bodegraven Ad A, Alizadeh Behrooz Z, Peña A Salvador. CARD15 gene and the classification of Crohn's disease. Immunogenetics. 2002 Apr;54(1):59–61. [PubMed]
  • van der Paardt M, Crusius JBA, de Koning MHMT, Murillo LS, van de Stadt RJ, Dijkmans BAC, Peña AS, van der Horst-Bruinsma IE. CARD15 gene mutations are not associated with ankylosing spondylitis. Genes Immun. 2003 Jan;4(1):77–78. [PubMed]
  • Ferreirós-Vidal Isabel, Amarelo Juan, Barros Francisco, Carracedo Angel, Gómez-Reino Juan J, Gonzalez Antonio. Lack of association of ankylosing spondylitis with the most common NOD2 susceptibility alleles to Crohn's disease. J Rheumatol. 2003 Jan;30(1):102–104. [PubMed]
  • Crane Alison M, Bradbury Linda, van Heel David A, McGovern Dermot P B, Brophy Sinead, Rubin Laurence, Siminovitch Katherine A, Wordsworth B Paul, Calin Andrei, Brown Matthew A. Role of NOD2 variants in spondylarthritis. Arthritis Rheum. 2002 Jun;46(6):1629–1633. [PubMed]
  • Beutler BA. The role of tumor necrosis factor in health and disease. J Rheumatol Suppl. 1999 May;57:16–21. [PubMed]
  • Beutler B. Autoimmunity and apoptosis: the Crohn's connection. Immunity. 2001 Jul;15(1):5–14. [PubMed]
  • Vercelli D. Learning from discrepancies: CD14 polymorphisms, atopy and the endotoxin switch. Clin Exp Allergy. 2003 Feb;33(2):153–155. [PubMed]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Group


Save items

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Gene
    Gene records that cite the current articles. Citations in Gene are added manually by NCBI or imported from outside public resources.
  • GEO Profiles
    GEO Profiles
    Gene Expression Omnibus (GEO) Profiles of molecular abundance data. The current articles are references on the Gene record associated with the GEO profile.
  • HomoloGene
    HomoloGene clusters of homologous genes and sequences that cite the current articles. These are references on the Gene and sequence records in the HomoloGene entry.
  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...